Brief: Intelgenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related To Rizaport NDA
30/01/2019 13:07
Jan 30 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX FACILITY UNDERGOES U.S. FDA PRE-APPROVAL
INSPECTION
RELATED TO RIZAPORT NDA
* INTELGENX TECHNOLOGIES CORP - FDA HAS ASSIGNED A PDUFA
GOAL DATE
OF APRIL 1, 2019, FOR COMPLETION OF REVIEW OF RESUBMITTED NDA
FOR RIZAPORT
Source text for Eikon: ID:nGNX4L0Bg6
Further company coverage: IGX.V
((Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA